ftInvstr
KILITCH · Healthcare ₹180.95 +4.35% Mkt Cap ₹634 Cr
← Search another stock

KILITCH

Healthcare Drug Manufacturers - Specialty & Generic
★ Watchlist ⧉ Add to bucket
₹180.95
+4.35% today · 30d -6.64%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for KILITCH. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹45 Cr
+4.03% YoY
NET PROFIT
₹2 Cr
-13.04% YoY
OPM
12.21%
-0.53pp YoY
EPS
₹0.83
PE 21.37
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-11.9% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
KILITCH21.3714.0
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
62
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 75
Valuation REASONABLE 60
Growth STEADY 66
Profitability DECENT 58
Technicals NEUTRAL 62
Risk MODERATE 50
Key Stats
TTM PE
21.37
P/B
2.35
52W HIGH
₹219.5
OFF HIGH
-17.56%
MKT CAP
₹634 Cr
◉ Active Signals
MACDNeutral1.0964
RSI(14)Neutral55.21
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold KILITCH and at what entry.

Sign up freeSign in
AI-generated research based on publicly available data and ftInvstr's bias-safe quantitative models. Not investment advice. Past performance does not guarantee future results. Consult a SEBI-registered investment adviser before making any investment decision.